 |
|
An effective strategy for inhibition of cirrhosis
September 25, 2008In China, the incidence of liver cirrhosis is still high, although new therapeutic approaches have recently been proposed, there is no established therapy for liver fibrosis, and Authors investigated the prevention effects of Chinese Medicine Qianggan-Rongxian Soup on liver fibrosis induced by DMN in rat. Chinese Medicin Qianggan-Rongxian decoction can inhibit hepatic fibrosis resulted from chronic liver injure, retard the development of cirrhosis, and notably ameliorate the liver function. It may be a safe and effective therapeutic drug for patients with fibrosis.
A research article to be published on 14 June 2008, in the World Journal of Gastroenterology addresses this question. The research team led by Chun-Hui Li from affiliated Hospital of Chengde Medicine College studied the inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat.
Qianggan-Rongxian decoction, especially the medium-dose administration could decrease the area-density percentage of collagen fibrosis. HA, LN, and type IV collagen are good serum markers of hepatic fibrosis. In this study, the serum contents of these 3 markers in the model group were much higher than those of the controls. And the Qianggan-Rongxian decoction groups had significantly low HA, LN, and type IV collagen levels in serum than those in the controls, ALT and AST are indexes to describe liver functions. Most part of ALT is presented in the cytoplasm of liver cell, discharged in blood when degeneration, hyper permeability and necrosis of liver cells occur. So the increase of ALT level in serum reflects the degree of liver cell injury. Our study showed that the Qianggan-Rongxian decoction could decrease serum levels of ALT and AST in rats with hepatic injury caused by DMN. It indicates that Qianggan-Rongxian decoction may work through protecting the liver cells, which indicated that Qianggan-Rongxian decoction could successfully prevent hepatic fibrosis.
The mechanism of DMN-induced liver fibrosis has been shown to be associated with immune function, which is similar to the mechanism of human liver fibrosis. Thus, DMN-induced rat liver fibrosis may be a useful model for determination of liver fibrosis during drug screenin. The mechanism of the Qianggan-Rongxian decoction may need further research.
This study may provide a safe and effective strategy for inhibition of cirrhosis in clinic use.
World Journal of Gastroenterology
The mechanism of DMN-induced liver fibrosis has been shown to be associated with immune function, which is similar to the mechanism of human liver fibrosis. Thus, DMN-induced rat liver fibrosis may be a useful model for determination of liver fibrosis during drug screenin. The mechanism of the Qianggan-Rongxian decoction may need further research.
This study may provide a safe and effective strategy for inhibition of cirrhosis in clinic use.
World Journal of Gastroenterology
Liver Fibrosis Current Events and Liver Fibrosis News RSSMayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease
A new study shows that an imaging technology developed by Mayo Clinic researchers can identify liver fibrosis with high accuracy and help eliminate the need for liver biopsies. Liver fibrosis is a common condition that can lead to incurable cirrhosis if not treated in time.
Are bone marrow mononuclear cells effective in reducing hepatic lesions?
Liver fibrosis occurs in the setting of chronic injury caused by different etiologies constituting a serious worldwide public health problem. In addition to schistosomiasis, hepatopathies due to alcohol, viral hepatitis, drugs, metabolic and autoimmune diseases, and congenital abnormalities are important causes of liver fibrosis.
The natural history of 'healthy-HCV carriers'
A normal liver is observed in about 10% of HCV infected patients and the natural history of theses so-called "healthy-HCV carriers" is not fully defined.
Noninvasive test accurately identifies advanced liver disease without biopsy
Non-invasively measuring liver stiffness with transient elastography accurately diagnoses patients with late-stage liver disease, reports a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
To protect against liver disease, body puts cells 'under arrest'
A stable form of cell-cycle arrest known to offer potent protection against cancer also limits liver fibrosis, a condition characterized by an excess of fibrous tissue, according to a new report in the August 22nd Cell, a Cell Press publication.
Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage
Although post-reproductive life in humans is often associated with decline and a loss of powers, an analogous state in certain cells -- called senescence -- is proving to be one of ironic potency. Scientists at Cold Spring Harbor Laboratory (CSHL) today reported that a particular class of senescent liver cells orchestrates a sequence of events in living mice that can limit fibrosis, a natural response of the liver to acute damage.
Study shows positive findings in treating patients with advanced hepatitis C
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
Study sheds important new light on inherited disorder causing iron overload
Research in today's New England Journal of Medicine (www.nejm.org) shows hereditary hemochromatosis is much more common than previously thought and will spur more study to determine who is most likely to develop complications from the debilitating and potentially fatal disease, write two faculty members at the Saint Louis University School of Medicine.
Attention: Extra-hepatic manifestation of hepatitis C virus infection
In 1994, the team of Tchernev and Petrova from Alexandrovska Hospital in Sofia examined a female patient with liver cirrhosis caused by chronic Hepatitis C virus (HCV).
Researchers show that fibrosis can be stopped, cured and reversed
University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed.
More Liver Fibrosis Current Events and Liver Fibrosis News Articles
| Fat Storing Cells and Liver Fibrosis (Falk Symposium) The field of liver fibrosis has become of great interest in the last decade. Although knowledge of the mechanisms leading to liver fibrogenesis and fibrosis has dramatically improved during the last 3--4 years, we are still at the edge of the truth. Several reports have stressed the role of nonparenchymal cells as the main producers of hepatic extra-cellular matrix. In particular,... | |
| Noninvasive device measures liver fibrosis.(Clinical Rounds): An article from: Family Practice News by Jeff Evans This digital document is an article from Family Practice News, published by International Medical News Group on March 15, 2005. The length of the article is 911 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Inhibition of C[Cl.sub.4]-induced liver fibrosis by Piper longum Linn.?(SHORT COMMUNICATION) : An article from: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology by A.J.M. Christina, G.R. Saraswathy, S.J. Heison Robert, R. Kothai, N. Chidambaranathan, G. Nalini, R.L. Therasal This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Thomson Gale on February 1, 2006. The length of the article is 2153 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view... | |
| Reduction, not abstinence, found effective for heavy drinkers. (Brief Intervention Slows Liver Fibrosis).: An article from: Internal Medicine News This digital document is an article from Internal Medicine News, published by International Medical News Group on December 15, 2002. The length of the article is 443 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
| SUR9 Heart-lung-liver transplant for cystic fibrosis. (Surgery).(Brief Article): An article from: Southern Medical Journal by Paul E. Wise, J. Kelly Wright, William C. Chapman, Davis C., Jr. Drinkwater, Robin N. Pierson, C. Wright Pinson This digital document is an article from Southern Medical Journal, published by Southern Medical Association on December 1, 2001. The length of the article is 350 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
 | Cooperation of Liver Cells in Health and Disease by Z. Kmiec Medical Univ. of Gdansk, Poland. Summarizes multiple data suggesting the role of cellular cross-talk for the functions of normal and diseased liver. Includes a concise presentation of the majority of detailed data in 18 tables. Expanded-outline format. Softcover. DNLM:... |
| Blood test could replace liver biopsy for MTX users: hepatic fibrosis unlikely with normal result. (PIIINP).(methotrexate): An article from: Skin & Allergy News by Kathryn Demott This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 572 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
 | The activin axis in liver biology and disease [An article from: Mutation Research-Reviews in Mutation Research] by C. Rodgarkia-Dara, S. Vejda, N. Erlach, A. Losert This digital document is a journal article from Mutation Research-Reviews in Mutation Research, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Activins are a closely related subgroup within the TGF@b superfamily of growth and differentiation... |
| Molecular and Cell Biology of Liver Fibrogenesis (Falk Symposium) This volume, the proceedings of the International Falk Symposium held in Marburg, Germany, in January 1992, summarizes the most recent advances in the study of cellular and molecular mechanisms of fibrosis provided by contributions from the leading scientists in this field. It updates our knowledge on the basic components of fibrosis, on the cellularorigin and degradation of matrix... | |
| Fibrosis of the liver in West African children (Special reports; no.285) by Medical Research Council |
| © 2008 BrightSurf.com |